## FDA Brain Drain: Former Regulators Allege Institutional Strain as Six Ex-Officials Detail Departures Under Trump Administration
Six former senior officials at the U.S. Food and Drug Administration are speaking out about their decisions to leave the agency during the second Trump administration, describing a work environment transformed by DOGE Service cuts that reshaped federal operations over the past year. Their testimonies, gathered by STAT reporter Lizzy Lawrence in a series of interviews conducted across the Washington suburbs, offer a rare window into the human consequences of workforce reductions at one of the nation's most consequential regulatory bodies.

Among those sharing their stories are Richard Pazdur, former director of the FDA's Center for Drug Evaluation and Research; Sheryl Lard-Whiteford, who held a leadership position in the agency's biologics center; and Julie Tierney, a veteran of Operation Warp Speed. The officials discussed what originally drew them to the FDA, the significant work they contributed during their tenures, and ultimately the factors that prompted their departures. The interviews were compiled into a special road-trip edition of STAT's podcast, STATus Report.

The departures raise questions about institutional continuity at an agency responsible for regulating pharmaceuticals, medical devices, and biologics that reach millions of Americans. While the source does not quantify staff losses or describe specific operational disruptions, the accumulation of experienced voices choosing to leave signals potential pressure on the agency's regulatory capacity and historical knowledge base during a period of federal restructuring.
---
- **Source**: STAT News
- **Sector**: The Office
- **Tags**: FDA, DOGE, federal workforce, regulatory agencies, Trump administration
- **Credibility**: unverified
- **Published**: 2026-05-08 09:24:41
- **ID**: 80541
- **URL**: https://whisperx.ai/en/intel/80541